Once-weekly Tirzepatide Versus Once-daily Insulin Degludec as Add-on to Metformin With or Without SGLT2 Inhibitors in Patients With Type 2 Diabetes (SURPASS-3): A Randomised, Open-label, Parallel-group, Phase 3 Trial.
Crucially, the study included a calorie-restricted pair-fed group whose daily food intake was matched to the semaglutide group to isolate the effect of the drug from the effect of eating less
Here are some non-drug treatments that can help: Dietary Changes: Following a healthy diet is crucial for managing diabetes
Are there serious side effects with tirzepatide
These estimates suggest that approximately 1 in 5 men or women will eventually be diagnosed with cancer, and about 1 in 9 men and 1 in 12 women will die from cancer ( Strategies for cancer treatment always prioritize selectively eliminating cancer cells while minimizing damage to healthy cells
The aim of this study was to assess the prognostic significance of serum HDL-cholesterol concentrations in representative, community-based participants from the Fremantle Diabetes Study Phase II (FDS2)
